Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee

Psychiatric Services

Volumn 55, Issue 11, 2004, Pages 1210-1212

  Gottlieb, Diane ^a   Dubin, William R ^a   Ning, Autumn ^a   Gardiner, George C ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Comm Behav Health in Philadelphia ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DRUG BIOAVAILABILITY; EXPERIENCE; HEALTH CARE QUALITY; MANAGED CARE; PHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCHIATRY; RESPONSIBILITY; REVIEW;

BUDGETS; COST SAVINGS; DISSENT AND DISPUTES; DRUG COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INSURANCE BENEFITS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAID; MENTAL DISORDERS; PENNSYLVANIA; PHARMACY AND THERAPEUTICS COMMITTEE; PSYCHOTROPIC DRUGS;

EID: 7444248408     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.11.1210     Document Type: Review

References (7)

1. Huskamp H: Managing psychotropic drug costs: will formularies work? Health Affairs 22(5):84-96,2003
2. Schreter RK: Managed pharmacy: a new direction in cost containment. Psychiatric Practice and Managed Care 6(1):4, 2000
3. Sabin JE, Daniels N: Improving psychiatric-drug benefit management: I. Lessons from Massachusetts. Psychiatric Services 54: 949-951, 2003
4. Sabin JE, Daniels N: Improving psychiatric drug benefit management: II. Kaiser Permanente's approach to SSRIs. Psychiatric Services 54:1343-1349, 2003
5. Sabin JE, Daniels N: Improving psychiatric drug benefit management: III. The VA's approach to atypical antipsychotics. Psychiatric Services 55:22-25, 2004
6. Miller AL, Chiles JA, Chiles JK, et al: The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry 60:649-657, 1999
7. Daniels N, Teagarden R, Sabin J: An ethical template for pharmacy benefits. Health Affairs 22(1): 125-137, 2003